| Glaxosmithkline Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500660 |
NSE Symbol : GLAXO |
P/E(TTM) : 41.08 |
|
ISIN Demat : INE159A01016 |
Div & Yield% : 2.22 |
EPS(TTM) : 62.48 |
|
Book Value(₹) : 132.30 |
Market Cap(₹Cr) : 43,478.91 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 924.42 | 989.15 | 1,022.59 | 973.63 | 804.83 | 966.08 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 924.42 | 989.15 | 1,022.59 | 973.63 | 804.83 | 966.08 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 61.63 | 35.71 | 31.82 | 33.91 | 43.76 | 39.46 |
| Total Income | 986.05 | 1,024.86 | 1,054.41 | 1,007.54 | 848.59 | 1,005.54 |
| Total Expenditure | 631.26 | 641.96 | 655.01 | 638.95 | 554.08 | 635.34 |
| PBIDT | 354.79 | 382.90 | 399.40 | 368.59 | 294.51 | 370.20 |
| Interest | 0.97 | 0.61 | 1.19 | 0.51 | 0.42 | 0.58 |
| PBDT | 353.82 | 382.29 | 398.21 | 368.08 | 294.09 | 369.62 |
| Depreciation | 15.84 | 13.17 | 20.32 | 17.43 | 15.52 | 14.72 |
| Tax | 81.35 | 87.24 | 98.65 | 95.21 | 73.85 | 89.34 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.30 | 6.94 | 2.06 | 0.44 | 0.02 | 5.42 |
| Reported Profit After Tax | 253.33 | 274.94 | 277.18 | 255.00 | 204.70 | 260.14 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 1.92 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 253.33 | 274.94 | 277.18 | 253.08 | 204.70 | 260.14 |
| EPS (Unit Curr.) | 14.95 | 16.23 | 16.36 | 14.92 | 12.08 | 15.35 |
| EPS (Adj) (Unit Curr.) | 14.95 | 16.23 | 16.36 | 14.92 | 12.08 | 15.35 |
| Calculated EPS (Unit Curr.) | 14.95 | 16.23 | 16.36 | 15.05 | 12.08 | 15.36 |
| Calculated EPS (Adj) (Unit Curr.) | 14.95 | 16.23 | 16.36 | 15.05 | 12.08 | 15.36 |
| Calculated EPS (Ann.) (Unit Curr.) | 59.81 | 64.92 | 65.45 | 60.21 | 48.33 | 61.42 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 59.81 | 64.92 | 65.45 | 60.21 | 48.33 | 61.42 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 38.38 | 38.71 | 39.06 | 37.86 | 36.59 | 38.32 |
| PBDTM(%) | 38.27 | 38.65 | 38.94 | 37.80 | 36.54 | 38.26 |
| PATM(%) | 27.40 | 27.80 | 27.11 | 26.19 | 25.43 | 26.93 |
